Drugs / Quiklean®
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03992365 | Jun → Oct 2019 | — | Universal Integrated Corp. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Quiklean | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03992365 ↗ |
| Route | Oral | “Take 4 tablets with 250 ml of clear liquids every 15 minutes” NCT03992365 ↗ |